Thomas P. Leist, MD, PhD, FAAN
Professor
Division Chief, Multiple Sclerosis/Neuroimmunology
Fellowship Program Director, Multiple Sclerosis/Neuroimmunology
Contact
900 Walnut Street
Second Floor
Philadelphia, PA 19107
215-955-6871
215-503-2990 fax
Thomas P. Leist, MD, PhD, FAAN
Professor
Division Chief, Multiple Sclerosis/Neuroimmunology
Fellowship Program Director, Multiple Sclerosis/Neuroimmunology
Education
Medical School
MD, University of Miami School of Medicine
PhD, University of Zurich, Switzerland
Residency
Cornell Medical Center
Fellowship
National Institute of Health
UCLA
Univesity of Zurich, Switzerland
Publications
- Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
- Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial
- Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: A plain language summary
- Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability
- Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies
Board Certification
Neurology
Hospital Appointment
Thomas Jefferson University Hospital